Market Size
The global plasma for fractionation market was valued at USD 9,541 million in 2023 and is projected to reach USD 18,446.09 million by 2032, exhibiting a CAGR of 7.60% during the forecast period.
Key Market Statistics:
-
Market Size in 2023: USD 9,541 million
-
Projected Market Size by 2032: USD 18,446.09 million
-
CAGR (2023-2032): 7.60%
The market is growing rapidly due to increasing demand for plasma-derived therapies, rising awareness about plasma donation, and advancements in fractionation techniques. Additionally, the global rise in the prevalence of chronic diseases and autoimmune disorders is contributing to the expanding need for plasma-based treatments.
The plasma for fractionation market plays a critical role in the healthcare and pharmaceutical industries by providing life-saving treatments derived from human blood plasma. Plasma fractionation is the process by which plasma is separated into its individual components, with each fraction having different therapeutic uses. This market is experiencing significant growth, driven by the increasing demand for plasma-based therapies and advancements in fractionation technology. In this article, we will provide an in-depth analysis of the global plasma for fractionation market, including its definition, market size, dynamics, regional analysis, and more.
Definition
Plasma for fractionation refers to the process of extracting plasma components from human blood for use in medical treatments. Plasma is rich in proteins, clotting factors, and immunoglobulins, which are essential for treating a wide range of health conditions such as immune deficiencies, clotting disorders, and autoimmune diseases. The fractionation process involves separating plasma into its various components using techniques like centrifugation and chromatography. These components are then used in the development of treatments and medications.
Some of the key products derived from plasma fractionation include:
-
Immunoglobulin (IVIG): Used to treat immune deficiencies.
-
Albumin: A protein used in treating burns, trauma, and hypoalbuminemia.
-
Clotting Factors: Used in treating hemophilia and other bleeding disorders.
-
Enzyme Replacement Therapies: For treating certain genetic disorders.
These plasma-derived therapies are essential for patients suffering from chronic and life-threatening conditions, making plasma for fractionation a vital sector within the healthcare and pharmaceutical industries.
Market Dynamics (Drivers, Restraints, Opportunities, and Challenges)
Drivers:
-
Increasing Demand for Plasma-Derived Therapies: The growing incidence of autoimmune diseases, hemophilia, and immunodeficiencies is driving the demand for plasma-derived therapies. These therapies have proven to be effective in managing and treating conditions that would otherwise be life-threatening.
-
Advancements in Plasma Fractionation Technology: Technological advancements in plasma fractionation methods are enhancing the efficiency and yield of plasma-derived products. These innovations are making it easier to isolate specific proteins and components from plasma, thus increasing the production of critical therapies.
-
Rising Healthcare Expenditure: Increased healthcare spending in developed and developing countries is making plasma-derived therapies more accessible. As healthcare systems continue to evolve, there is more funding available for plasma-based treatments, expanding the market further.
-
Awareness and Support for Plasma Donation: Efforts to raise awareness about the importance of plasma donation are helping ensure a steady supply of plasma, which is crucial for the market’s growth. Governments and organizations worldwide are encouraging plasma donation through educational campaigns and incentives.
Restraints:
-
Regulatory and Compliance Challenges: The plasma for fractionation market is heavily regulated, with stringent guidelines regarding the collection, processing, and use of human plasma. Compliance with these regulations can be time-consuming and costly, which may hinder the growth of new players in the market.
-
Supply Chain Issues: The collection of plasma is a complex and time-intensive process, and any disruption in the plasma supply chain can negatively affect the availability of plasma-derived products. Factors like geographical constraints and limited collection centers can impact the consistency of supply.
-
Ethical and Safety Concerns: There are ongoing concerns about the safety of plasma collection processes and the ethical implications of using human-derived materials in medical treatments. Stringent measures are in place to ensure safety, but public perception issues can limit market expansion.
Opportunities:
-
Expanding Plasma Donation Networks: There is a growing opportunity to expand plasma donation centers globally, especially in regions with insufficient plasma donation infrastructure. Increasing the number of donation centers will provide a steady supply of plasma for fractionation, addressing any supply shortfalls.
-
Emerging Markets: As the healthcare infrastructure in emerging markets such as Asia-Pacific, Latin America, and the Middle East continues to grow, the demand for plasma-derived therapies is also expected to rise. These regions present significant untapped potential for market expansion.
-
Developing Novel Therapies: Research into new applications for plasma-derived therapies, including gene therapies and personalized medicine, presents substantial growth opportunities. As new indications for plasma-derived products are discovered, the market is likely to expand in new and innovative ways.
Challenges:
-
Plasma Collection Shortages: One of the most significant challenges in the plasma for fractionation market is the limited availability of human plasma. As the demand for plasma-derived therapies increases, there is a growing need to secure a consistent and reliable supply of plasma.
-
High Cost of Plasma Fractionation: The process of fractionating plasma is expensive and requires significant investments in equipment, facilities, and expertise. This high cost can make plasma-derived therapies unaffordable for some regions or healthcare systems, limiting market penetration.
-
Global Competition: With the rising demand for plasma-derived therapies, the competition among pharmaceutical companies to secure a steady plasma supply is intensifying. This competition can lead to higher prices for plasma, making it more challenging for smaller companies to compete.
Regional Analysis
North America
North America, particularly the United States, is the largest market for plasma for fractionation, driven by a robust healthcare system, high demand for plasma-derived therapies, and the presence of major players such as Grifols and CSL Behring. The U.S. also has a well-established plasma donation infrastructure, which ensures a steady supply of plasma.
Europe
Europe is another major market for plasma for fractionation, with countries like Germany, the United Kingdom, and France being key contributors. European countries have strong healthcare systems and regulatory frameworks that support the growth of plasma-derived therapies.
Asia-Pacific
The Asia-Pacific region is expected to experience the fastest growth in the plasma for fractionation market. Rising healthcare standards, an increase in the prevalence of chronic diseases, and growing awareness of plasma donation are key drivers in countries like China and India.
Latin America
Latin America presents a promising market for plasma for fractionation due to the growing healthcare infrastructure and increasing demand for plasma-derived therapies. Countries like Brazil and Mexico are expected to see an increase in plasma donation and therapy usage.
Middle East & Africa
The Middle East & Africa market is in the early stages of development, but it is expected to grow significantly as healthcare systems improve. The region is also seeing an increase in demand for plasma-derived therapies due to the rise of chronic diseases and an aging population.
Competitor Analysis (in brief)
The global plasma for fractionation market is competitive, with key players holding significant market shares. These companies are focused on enhancing their fractionation technologies, expanding their plasma collection networks, and ensuring the safety and quality of their products. Notable players include:
-
Grifols: A leading player in the plasma-derived therapies market, known for its global presence and extensive product portfolio.
-
CSL Behring: A major player in the plasma for fractionation space, specializing in immunoglobulins, albumin, and clotting factors.
-
Kedrion Biopharma: Known for its range of plasma-based products, particularly in the areas of immunology and hematology.
-
Octapharma: A prominent manufacturer of human proteins, including plasma-derived therapies for immune and clotting disorders.
-
Baxter International: A global healthcare company offering a variety of plasma-derived therapies and medical solutions.
Global Plasma for Fractionation Market: Market Segmentation Analysis
This report provides a deep insight into the global plasma for fractionation market, covering all its essential aspects. This ranges from a macro overview of the market to micro details of market size, competitive landscape, development trends, niche markets, key drivers, and challenges. The analysis helps readers to understand the competitive environment and form strategies to enhance profit potential. Furthermore, it offers a comprehensive understanding of the market share, product situation, and competitive landscape.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those with an interest in the plasma for fractionation market.
Market Segmentation (by Application)
Market Segmentation (by Type)
Key Company
-
Grifols
-
CSL Behring
-
Kedrion Biopharma
-
Octapharma
-
Baxter International
Geographic Segmentation
-
North America
-
Europe
-
Asia-Pacific
-
Latin America
-
Middle East & Africa
FAQs
1.What is the current market size of the Plasma for Fractionation market?
- The plasma for fractionation market was valued at USD 9,541 million in 2023 and is projected to reach USD 18,446.09 million by 2032.
2.Which are the key companies operating in the Plasma for Fractionation market?
- Key players in the plasma for fractionation market include Grifols, CSL Behring, Kedrion Biopharma, Octapharma, and Baxter International.
3.What are the key growth drivers in the Plasma for Fractionation market?
- Key growth drivers include the increasing demand for plasma-derived therapies, advancements in fractionation technology, and rising healthcare expenditure worldwide.
4.Which regions dominate the Plasma for Fractionation market?
- North America, Europe, and Asia-Pacific dominate the plasma for fractionation market, with Asia-Pacific expected to experience the fastest growth.
5.What are the emerging trends in the Plasma for Fractionation market?
- Emerging trends include expanding plasma donation networks, the development of novel plasma-derived therapies, and increased market penetration in emerging markets like Asia-Pacific and Latin America
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Plasma for Fractionation
1.2 Key Market Segments
1.2.1 Plasma for Fractionation Segment by Type
1.2.2 Plasma for Fractionation Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Plasma for Fractionation Market Overview
2.1 Global Market Overview
2.1.1 Global Plasma for Fractionation Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Plasma for Fractionation Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Plasma for Fractionation Market Competitive Landscape
3.1 Global Plasma for Fractionation Sales by Manufacturers (2019-2025)
3.2 Global Plasma for Fractionation Revenue Market Share by Manufacturers (2019-2025)
3.3 Plasma for Fractionation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Plasma for Fractionation Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Plasma for Fractionation Sales Sites, Area Served, Product Type
3.6 Plasma for Fractionation Market Competitive Situation and Trends
3.6.1 Plasma for Fractionation Market Concentration Rate
3.6.2 Global 5 and 10 Largest Plasma for Fractionation Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Plasma for Fractionation Industry Chain Analysis
4.1 Plasma for Fractionation Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Plasma for Fractionation Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Plasma for Fractionation Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Plasma for Fractionation Sales Market Share by Type (2019-2025)
6.3 Global Plasma for Fractionation Market Size Market Share by Type (2019-2025)
6.4 Global Plasma for Fractionation Price by Type (2019-2025)
7 Plasma for Fractionation Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Plasma for Fractionation Market Sales by Application (2019-2025)
7.3 Global Plasma for Fractionation Market Size (M USD) by Application (2019-2025)
7.4 Global Plasma for Fractionation Sales Growth Rate by Application (2019-2025)
8 Plasma for Fractionation Market Consumption by Region
8.1 Global Plasma for Fractionation Sales by Region
8.1.1 Global Plasma for Fractionation Sales by Region
8.1.2 Global Plasma for Fractionation Sales Market Share by Region
8.2 North America
8.2.1 North America Plasma for Fractionation Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Plasma for Fractionation Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Plasma for Fractionation Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Plasma for Fractionation Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Plasma for Fractionation Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Plasma for Fractionation Market Production by Region
9.1 Global Production of Plasma for Fractionation by Region (2019-2025)
9.2 Global Plasma for Fractionation Revenue Market Share by Region (2019-2025)
9.3 Global Plasma for Fractionation Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Plasma for Fractionation Production
9.4.1 North America Plasma for Fractionation Production Growth Rate (2019-2025)
9.4.2 North America Plasma for Fractionation Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Plasma for Fractionation Production
9.5.1 Europe Plasma for Fractionation Production Growth Rate (2019-2025)
9.5.2 Europe Plasma for Fractionation Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Plasma for Fractionation Production (2019-2025)
9.6.1 Japan Plasma for Fractionation Production Growth Rate (2019-2025)
9.6.2 Japan Plasma for Fractionation Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Plasma for Fractionation Production (2019-2025)
9.7.1 China Plasma for Fractionation Production Growth Rate (2019-2025)
9.7.2 China Plasma for Fractionation Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Takeda
10.1.1 Takeda Plasma for Fractionation Basic Information
10.1.2 Takeda Plasma for Fractionation Product Overview
10.1.3 Takeda Plasma for Fractionation Product Market Performance
10.1.4 Takeda Business Overview
10.1.5 Takeda Plasma for Fractionation SWOT Analysis
10.1.6 Takeda Recent Developments
10.2 CSL
10.2.1 CSL Plasma for Fractionation Basic Information
10.2.2 CSL Plasma for Fractionation Product Overview
10.2.3 CSL Plasma for Fractionation Product Market Performance
10.2.4 CSL Business Overview
10.2.5 CSL Plasma for Fractionation SWOT Analysis
10.2.6 CSL Recent Developments
10.3 Grifols
10.3.1 Grifols Plasma for Fractionation Basic Information
10.3.2 Grifols Plasma for Fractionation Product Overview
10.3.3 Grifols Plasma for Fractionation Product Market Performance
10.3.4 Grifols Plasma for Fractionation SWOT Analysis
10.3.5 Grifols Business Overview
10.3.6 Grifols Recent Developments
10.4 Octapharma
10.4.1 Octapharma Plasma for Fractionation Basic Information
10.4.2 Octapharma Plasma for Fractionation Product Overview
10.4.3 Octapharma Plasma for Fractionation Product Market Performance
10.4.4 Octapharma Business Overview
10.4.5 Octapharma Recent Developments
10.5 Kedrion
10.5.1 Kedrion Plasma for Fractionation Basic Information
10.5.2 Kedrion Plasma for Fractionation Product Overview
10.5.3 Kedrion Plasma for Fractionation Product Market Performance
10.5.4 Kedrion Business Overview
10.5.5 Kedrion Recent Developments
10.6 LFB Group
10.6.1 LFB Group Plasma for Fractionation Basic Information
10.6.2 LFB Group Plasma for Fractionation Product Overview
10.6.3 LFB Group Plasma for Fractionation Product Market Performance
10.6.4 LFB Group Business Overview
10.6.5 LFB Group Recent Developments
10.7 Biotest
10.7.1 Biotest Plasma for Fractionation Basic Information
10.7.2 Biotest Plasma for Fractionation Product Overview
10.7.3 Biotest Plasma for Fractionation Product Market Performance
10.7.4 Biotest Business Overview
10.7.5 Biotest Recent Developments
10.8 BPL
10.8.1 BPL Plasma for Fractionation Basic Information
10.8.2 BPL Plasma for Fractionation Product Overview
10.8.3 BPL Plasma for Fractionation Product Market Performance
10.8.4 BPL Business Overview
10.8.5 BPL Recent Developments
10.9 RAAS
10.9.1 RAAS Plasma for Fractionation Basic Information
10.9.2 RAAS Plasma for Fractionation Product Overview
10.9.3 RAAS Plasma for Fractionation Product Market Performance
10.9.4 RAAS Business Overview
10.9.5 RAAS Recent Developments
10.10 CBPO
10.10.1 CBPO Plasma for Fractionation Basic Information
10.10.2 CBPO Plasma for Fractionation Product Overview
10.10.3 CBPO Plasma for Fractionation Product Market Performance
10.10.4 CBPO Business Overview
10.10.5 CBPO Recent Developments
10.11 Hualan Bio
10.11.1 Hualan Bio Plasma for Fractionation Basic Information
10.11.2 Hualan Bio Plasma for Fractionation Product Overview
10.11.3 Hualan Bio Plasma for Fractionation Product Market Performance
10.11.4 Hualan Bio Business Overview
10.11.5 Hualan Bio Recent Developments
11 Plasma for Fractionation Market Forecast by Region
11.1 Global Plasma for Fractionation Market Size Forecast
11.2 Global Plasma for Fractionation Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Plasma for Fractionation Market Size Forecast by Country
11.2.3 Asia Pacific Plasma for Fractionation Market Size Forecast by Region
11.2.4 South America Plasma for Fractionation Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Plasma for Fractionation by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Plasma for Fractionation Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Plasma for Fractionation by Type (2025-2032)
12.1.2 Global Plasma for Fractionation Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Plasma for Fractionation by Type (2025-2032)
12.2 Global Plasma for Fractionation Market Forecast by Application (2025-2032)
12.2.1 Global Plasma for Fractionation Sales (K MT) Forecast by Application
12.2.2 Global Plasma for Fractionation Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Plasma for Fractionation Market Size Comparison by Region (M USD)
Table 5. Global Plasma for Fractionation Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Plasma for Fractionation Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Plasma for Fractionation Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Plasma for Fractionation Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma for Fractionation as of 2022)
Table 10. Global Market Plasma for Fractionation Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Plasma for Fractionation Sales Sites and Area Served
Table 12. Manufacturers Plasma for Fractionation Product Type
Table 13. Global Plasma for Fractionation Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Plasma for Fractionation
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Plasma for Fractionation Market Challenges
Table 22. Global Plasma for Fractionation Sales by Type (K MT)
Table 23. Global Plasma for Fractionation Market Size by Type (M USD)
Table 24. Global Plasma for Fractionation Sales (K MT) by Type (2019-2025)
Table 25. Global Plasma for Fractionation Sales Market Share by Type (2019-2025)
Table 26. Global Plasma for Fractionation Market Size (M USD) by Type (2019-2025)
Table 27. Global Plasma for Fractionation Market Size Share by Type (2019-2025)
Table 28. Global Plasma for Fractionation Price (USD/MT) by Type (2019-2025)
Table 29. Global Plasma for Fractionation Sales (K MT) by Application
Table 30. Global Plasma for Fractionation Market Size by Application
Table 31. Global Plasma for Fractionation Sales by Application (2019-2025) & (K MT)
Table 32. Global Plasma for Fractionation Sales Market Share by Application (2019-2025)
Table 33. Global Plasma for Fractionation Sales by Application (2019-2025) & (M USD)
Table 34. Global Plasma for Fractionation Market Share by Application (2019-2025)
Table 35. Global Plasma for Fractionation Sales Growth Rate by Application (2019-2025)
Table 36. Global Plasma for Fractionation Sales by Region (2019-2025) & (K MT)
Table 37. Global Plasma for Fractionation Sales Market Share by Region (2019-2025)
Table 38. North America Plasma for Fractionation Sales by Country (2019-2025) & (K MT)
Table 39. Europe Plasma for Fractionation Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Plasma for Fractionation Sales by Region (2019-2025) & (K MT)
Table 41. South America Plasma for Fractionation Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Plasma for Fractionation Sales by Region (2019-2025) & (K MT)
Table 43. Global Plasma for Fractionation Production (K MT) by Region (2019-2025)
Table 44. Global Plasma for Fractionation Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Plasma for Fractionation Revenue Market Share by Region (2019-2025)
Table 46. Global Plasma for Fractionation Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Plasma for Fractionation Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Plasma for Fractionation Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Plasma for Fractionation Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Plasma for Fractionation Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Takeda Plasma for Fractionation Basic Information
Table 52. Takeda Plasma for Fractionation Product Overview
Table 53. Takeda Plasma for Fractionation Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Takeda Business Overview
Table 55. Takeda Plasma for Fractionation SWOT Analysis
Table 56. Takeda Recent Developments
Table 57. CSL Plasma for Fractionation Basic Information
Table 58. CSL Plasma for Fractionation Product Overview
Table 59. CSL Plasma for Fractionation Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. CSL Business Overview
Table 61. CSL Plasma for Fractionation SWOT Analysis
Table 62. CSL Recent Developments
Table 63. Grifols Plasma for Fractionation Basic Information
Table 64. Grifols Plasma for Fractionation Product Overview
Table 65. Grifols Plasma for Fractionation Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Grifols Plasma for Fractionation SWOT Analysis
Table 67. Grifols Business Overview
Table 68. Grifols Recent Developments
Table 69. Octapharma Plasma for Fractionation Basic Information
Table 70. Octapharma Plasma for Fractionation Product Overview
Table 71. Octapharma Plasma for Fractionation Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Octapharma Business Overview
Table 73. Octapharma Recent Developments
Table 74. Kedrion Plasma for Fractionation Basic Information
Table 75. Kedrion Plasma for Fractionation Product Overview
Table 76. Kedrion Plasma for Fractionation Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Kedrion Business Overview
Table 78. Kedrion Recent Developments
Table 79. LFB Group Plasma for Fractionation Basic Information
Table 80. LFB Group Plasma for Fractionation Product Overview
Table 81. LFB Group Plasma for Fractionation Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. LFB Group Business Overview
Table 83. LFB Group Recent Developments
Table 84. Biotest Plasma for Fractionation Basic Information
Table 85. Biotest Plasma for Fractionation Product Overview
Table 86. Biotest Plasma for Fractionation Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Biotest Business Overview
Table 88. Biotest Recent Developments
Table 89. BPL Plasma for Fractionation Basic Information
Table 90. BPL Plasma for Fractionation Product Overview
Table 91. BPL Plasma for Fractionation Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. BPL Business Overview
Table 93. BPL Recent Developments
Table 94. RAAS Plasma for Fractionation Basic Information
Table 95. RAAS Plasma for Fractionation Product Overview
Table 96. RAAS Plasma for Fractionation Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. RAAS Business Overview
Table 98. RAAS Recent Developments
Table 99. CBPO Plasma for Fractionation Basic Information
Table 100. CBPO Plasma for Fractionation Product Overview
Table 101. CBPO Plasma for Fractionation Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. CBPO Business Overview
Table 103. CBPO Recent Developments
Table 104. Hualan Bio Plasma for Fractionation Basic Information
Table 105. Hualan Bio Plasma for Fractionation Product Overview
Table 106. Hualan Bio Plasma for Fractionation Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Hualan Bio Business Overview
Table 108. Hualan Bio Recent Developments
Table 109. Global Plasma for Fractionation Sales Forecast by Region (2025-2032) & (K MT)
Table 110. Global Plasma for Fractionation Market Size Forecast by Region (2025-2032) & (M USD)
Table 111. North America Plasma for Fractionation Sales Forecast by Country (2025-2032) & (K MT)
Table 112. North America Plasma for Fractionation Market Size Forecast by Country (2025-2032) & (M USD)
Table 113. Europe Plasma for Fractionation Sales Forecast by Country (2025-2032) & (K MT)
Table 114. Europe Plasma for Fractionation Market Size Forecast by Country (2025-2032) & (M USD)
Table 115. Asia Pacific Plasma for Fractionation Sales Forecast by Region (2025-2032) & (K MT)
Table 116. Asia Pacific Plasma for Fractionation Market Size Forecast by Region (2025-2032) & (M USD)
Table 117. South America Plasma for Fractionation Sales Forecast by Country (2025-2032) & (K MT)
Table 118. South America Plasma for Fractionation Market Size Forecast by Country (2025-2032) & (M USD)
Table 119. Middle East and Africa Plasma for Fractionation Consumption Forecast by Country (2025-2032) & (Units)
Table 120. Middle East and Africa Plasma for Fractionation Market Size Forecast by Country (2025-2032) & (M USD)
Table 121. Global Plasma for Fractionation Sales Forecast by Type (2025-2032) & (K MT)
Table 122. Global Plasma for Fractionation Market Size Forecast by Type (2025-2032) & (M USD)
Table 123. Global Plasma for Fractionation Price Forecast by Type (2025-2032) & (USD/MT)
Table 124. Global Plasma for Fractionation Sales (K MT) Forecast by Application (2025-2032)
Table 125. Global Plasma for Fractionation Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Plasma for Fractionation
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Plasma for Fractionation Market Size (M USD), 2019-2032
Figure 5. Global Plasma for Fractionation Market Size (M USD) (2019-2032)
Figure 6. Global Plasma for Fractionation Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Plasma for Fractionation Market Size by Country (M USD)
Figure 11. Plasma for Fractionation Sales Share by Manufacturers in 2023
Figure 12. Global Plasma for Fractionation Revenue Share by Manufacturers in 2023
Figure 13. Plasma for Fractionation Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Plasma for Fractionation Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Plasma for Fractionation Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Plasma for Fractionation Market Share by Type
Figure 18. Sales Market Share of Plasma for Fractionation by Type (2019-2025)
Figure 19. Sales Market Share of Plasma for Fractionation by Type in 2023
Figure 20. Market Size Share of Plasma for Fractionation by Type (2019-2025)
Figure 21. Market Size Market Share of Plasma for Fractionation by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Plasma for Fractionation Market Share by Application
Figure 24. Global Plasma for Fractionation Sales Market Share by Application (2019-2025)
Figure 25. Global Plasma for Fractionation Sales Market Share by Application in 2023
Figure 26. Global Plasma for Fractionation Market Share by Application (2019-2025)
Figure 27. Global Plasma for Fractionation Market Share by Application in 2023
Figure 28. Global Plasma for Fractionation Sales Growth Rate by Application (2019-2025)
Figure 29. Global Plasma for Fractionation Sales Market Share by Region (2019-2025)
Figure 30. North America Plasma for Fractionation Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Plasma for Fractionation Sales Market Share by Country in 2023
Figure 32. U.S. Plasma for Fractionation Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Plasma for Fractionation Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Plasma for Fractionation Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Plasma for Fractionation Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Plasma for Fractionation Sales Market Share by Country in 2023
Figure 37. Germany Plasma for Fractionation Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Plasma for Fractionation Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Plasma for Fractionation Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Plasma for Fractionation Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Plasma for Fractionation Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Plasma for Fractionation Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Plasma for Fractionation Sales Market Share by Region in 2023
Figure 44. China Plasma for Fractionation Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Plasma for Fractionation Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Plasma for Fractionation Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Plasma for Fractionation Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Plasma for Fractionation Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Plasma for Fractionation Sales and Growth Rate (K MT)
Figure 50. South America Plasma for Fractionation Sales Market Share by Country in 2023
Figure 51. Brazil Plasma for Fractionation Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Plasma for Fractionation Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Plasma for Fractionation Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Plasma for Fractionation Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Plasma for Fractionation Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Plasma for Fractionation Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Plasma for Fractionation Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Plasma for Fractionation Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Plasma for Fractionation Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Plasma for Fractionation Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Plasma for Fractionation Production Market Share by Region (2019-2025)
Figure 62. North America Plasma for Fractionation Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Plasma for Fractionation Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Plasma for Fractionation Production (K MT) Growth Rate (2019-2025)
Figure 65. China Plasma for Fractionation Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Plasma for Fractionation Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Plasma for Fractionation Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Plasma for Fractionation Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Plasma for Fractionation Market Share Forecast by Type (2025-2032)
Figure 70. Global Plasma for Fractionation Sales Forecast by Application (2025-2032)
Figure 71. Global Plasma for Fractionation Market Share Forecast by Application (2025-2032)
